21/12/2009 (Agence Europe) - In a press release published on 18 December, the European Medicines Agency confirmed previously issued information on the effectiveness and patient tolerance of pandemic influenza vaccines Celvapan, Focetria and Pandemrix, and the antiviral Tamiflu. In the European Union, 26 million people have already been vaccinated and, worldwide, 13 million people took Tamiflu between 1 May and 31 October 2009. (O.J./transl.rt)